|
Volumn 39, Issue 9, 2014, Pages 1690-1694
|
Protection effect of Yindan Xinnaotong capsule and main compositions compatibility on myocardial ischemia/reperfusion injury
|
Author keywords
Main components compatibility; Myocardial ischemia reperfusion; Protection; Yindan Xinnaotong capsule
|
Indexed keywords
ANTIOXIDANT;
CALCIUM;
CHINESE DRUG;
CREATINE KINASE MB;
GINKGO BILOBA EXTRACT;
LACTATE DEHYDROGENASE;
MALONALDEHYDE;
METHANOL EXTRACTION RESIDUE;
SALVIA MILTIORRHIZA EXTRACT;
SUPEROXIDE DISMUTASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIOXIDANT ACTIVITY;
ARTICLE;
BLOOD LEVEL;
CARDIAC TROPONIN 1 CLIA KIT;
CONTROLLED STUDY;
DRUG CAPSULE;
ELECTROCARDIOGRAM;
HEART ARREST;
HEART ARRHYTHMIA;
HEART MUSCLE ISCHEMIA;
HEART PROTECTION;
NONHUMAN;
RAT;
REPERFUSION INJURY;
YINDAN XINNAOTONG CAPSULE;
ANIMALS;
ARRHYTHMIAS, CARDIAC;
CAPSULES;
CREATINE KINASE, MB FORM;
DRUGS, CHINESE HERBAL;
ELECTROCARDIOGRAPHY;
GINKGO BILOBA;
HEART;
L-LACTATE DEHYDROGENASE;
MALE;
MALONDIALDEHYDE;
MYOCARDIAL REPERFUSION INJURY;
MYOCARDIUM;
PHYTOTHERAPY;
PLANT EXTRACTS;
PROTECTIVE AGENTS;
RATS;
RATS, SPRAGUE-DAWLEY;
SALVIA MILTIORRHIZA;
SUPEROXIDE DISMUTASE;
TROPONIN I;
|
EID: 84903723469
PISSN: 10015302
EISSN: None
Source Type: Journal
DOI: 10.4268/cjcmm20140929 Document Type: Article |
Times cited : (5)
|
References (12)
|